ArticleNeurosurgical review2025
Overlooked cerebral venous features associated with disease progression in moyamoya disease: insights from a single-center case-control study.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive steno-occlusion of the internal carotid artery system and aberrant collateral vessel formation. While MMD is primarily recognized for its arterial pathology, venous changes have been less explored. In this study, we investigated cerebral venous features in MMD and their association with disease progression. A total of 129 MMD patients (219 hemispheres) and 219 control patients with intracranial aneurysms (219 healthy hemispheres) were evaluated using digital subtraction angiography. MMD patients demonstrated significantly lower venous scores (cortical, deep, and total) compared to controls, with scores further declining as the disease advanced. Additionally, MMD patients exhibited delayed cortical venous filling times, which correlated with higher Suzuki stages. Venous drainage patterns also differed, with MMD patients predominantly showing posterior drainage, whereas controls exhibited anterior drainage. These findings underscore significant venous abnormalities in MMD, suggesting that the disease affects both the arterial and venous systems, challenging the conventional view of MMD as solely an arterial disorder.
Indexed as
Identifiers
39961880What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.